BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

22 hedge funds and large institutions have $8.2M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
4
Calls
$2.59M
Puts
$1.21M
Net Calls
+$1.38M
Net Calls Change
+$2.05M

Top Buyers

1
IMC Chicago
1
IMC Chicago
Illinois
$2.43M
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.47M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.08M
4
PWM
4
Palumbo Wealth Management
New York
$228K
5
Simplex Trading
5
Simplex Trading
Illinois
$141K

Top Sellers

1
CCWM
1
Cassaday & Co Wealth Management
Virginia
$257K
2
JF
2
Jump Financial
Illinois
$0
3
Vontobel Holding
3
Vontobel Holding
Switzerland
$0
4
TRCT
4
Tower Research Capital (TRC)
New York
$82.3K
5
TCBWMS
5
Texas Capital Bank Wealth Management Services
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
– -$40.7K -849 Closed
1
2